Compare LTC Properties Inc (LTC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs Zoetis Inc — how do they compare? LTC Properties Inc trades at $38.73 (market cap $2.05B), while Zoetis Inc trades at $72.99 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 15.2× LTC Properties Inc's market cap, and LTC Properties Inc pays the higher dividend (5.98%). Which is the better fit depends on your goals.
| LTC | ZTS | |
|---|---|---|
Market Cap | $2.05B | $31.14B |
Sector | Real Estate | Health |
52-Week High | $42.81 | $156.76 |
52-Week Low | $33.98 | $71.91 |
Enterprise Value | $2.79B | $38.70B |
Dividend Yield | 5.98% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LTC Properties trades at $38.77, down 1.65% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $262.85 million in 2025, with a net income margin of 38.93%, and maintains a P/E ratio of 13.61. Recent news highlights active SHOP portfolio expansion, including a $95 million acquisition, and consistent monthly dividends of $0.19 per share.
Outlook remains cautious due to bearish technicals and mixed analyst sentiment, though strong profitability and dividend yield offer support. Key risks include execution of aggressive acquisition strategy and debt levels. Upside depends on sustained revenue growth and successful integration of new properties.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
